Debra Van Egeren - Concepedia

Author

Debra Van Egeren

Also Known As

Debra Egeren, Debra S. Van Egeren, Debra Van Egeren, Debra van Egeren, Megan Heimann, Van Egeren, Debra, Van Egeren, Debra (Harvard University)

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Harvard University Dana-Farber Cancer Institute Boston Children's Hospital Center for Systems Biology University of Washington

About

Debra Van Egeren is an author at Harvard University specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Epidemiology	2	2	34
3	Public Health	1	1	12
4	Cell Biology	1	1	21
5	Global Health	1	1	12

Debra Van Egeren

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Structure-based programming of lymph-node targeting in molecular vaccines Haipeng Liu, Kelly D. Moynihan, Yiran Zheng, Nature VaccinationMedicineVaccine TargetImmunologyImmunotherapeutics	2014	923
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms Debra Van Egeren, Javier Escabi, Maximilian Nguyen, Cell stem cell	2021	204
Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines Gregory L. Szeto, Debra Van Egeren, Hermoon Worku, Europe PMC (PubMed Central)	2015	98
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, PLoS ONE Biomedical InterventionsViral PathogenesisImmunologyViral Structural ProteinImmunotherapy	2021	95
Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Rbd-targeting NabsViral PathogenesisImmunologyViral Structural ProteinBroad-spectrum Vaccines	2020	26
Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Scientific Reports	2021	24
Individually optimal choices can be collectively disastrous in COVID-19 disease control Madison Stoddard, Debra Van Egeren, Kaitlyn E. Johnson, BMC Public Health	2021	22
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2 Debra Van Egeren, Madison Stoddard, Laura F. White, Vaccines VaccinationImmune EvasionVaccine DevelopmentVaccine TargetTransmission Rates	2023	22
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms Debra Van Egeren, Baransel Kamaz, Shichen Liu, Experimental Hematology Hematological MalignancyHematologyImmunologyPathologyMyeloproliferative Neoplasms	2021	21
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis Debra Van Egeren, Khushi Kohli, Jeremy L. Warner, Scientific Reports	2022	19

Page 1